Jen Kanakry

National Institutes of Health - Bethesda / United States

Others

AD Scientific Index ID: 4397792

Registration, Add Profile,
Premium Membership

Print Your Certificate

Jen Kanakry's MOST POPULAR ARTICLES

1-) T cells genetically modified to express an anti–B-cell maturation antigen chimeric antigen receptor cause remissions of poor-prognosis relapsed multiple myelomaJN Brudno, I Maric, SD Hartman, JJ Rose, M Wang, N Lam, ...Journal of Clinical Oncology 36 (22), 2267-2280, 20185382018

2-) Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamideSR McCurdy, JA Kanakry, MM Showel, HL Tsai, J Bolaños-Meade, ...Blood, The Journal of the American Society of Hematology 125 (19), 3024-3031, 20152652015

3-) Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adultsYL Kasamon, J Bolaños-Meade, GT Prince, HL Tsai, SR McCurdy, ...Journal of Clinical Oncology 33 (28), 3152, 20152202015

4-) TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancersNB Nagarsheth, SM Norberg, AL Sinkoe, S Adhikary, TJ Meyer, JB Lack, ...Nature medicine 27 (3), 419-425, 20212502021

5-) Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDSCG Kanakry, HL Tsai, J Bolaños-Meade, BD Smith, I Gojo, JA Kanakry, ...Blood, The Journal of the American Society of Hematology 124 (25), 3817-3827, 20142192014

ARTICLES

Add your articles